The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition and patient well-being

Diabetes, Obesity and Metabolism

Volumn 9, Issue 1, 2007, Pages 143-145

  Moon, R J ^a   Bascombe, L A ^a   Holt, R I G ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Clinical trial; Iinsulin sensitivity; Metformin; Quality of life; Type 1 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN;

ADJUVANT THERAPY; ADULT; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CLINICAL TRIAL; DIABETES CONTROL; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LONG TERM CARE; QUALITY OF LIFE; TREATMENT DURATION; WEIGHT REDUCTION; WELLBEING;

EID: 33845526229     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2006.00599.x     Document Type: Article

References (8)

1. Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: Results from the DCCT. Diabetes Control and Complications Trial. JAMA 1998; 280: 140-146.
2. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865.
3. Lakka HM, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
4. Bott U, Muhlhauser I, Overmann H, Berger M. Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes. Diabetes Care 1998; 21: 757-769.
5. Bradley C, Gamsu DS. Guidelines for encouraging psychological well-being. report of a Working Group of the World Health Organization Regional Office for Europe and International Diabetes Federation European Region St Vincent Declaration Action Programme for Diabetes. Diabet Med 1994; 11: 510-516.
6. Finegood DT, Hramiak IM, Dupre J. A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 1990; 70: 1538-1549.
7. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36: 936-942.
8. Sarnblad S, Kroon M, Aman J. Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: Randomised placebo-controlled trial with aspects on insulin sensitivity. Eur J Endocrinol 2003; 149: 323-329.